Finance

Lists
CASIF:OTCMKTS
CASI Pharmaceuticals Inc
$0.13
0.00%
(0.00) 1D
Aug 20, 12:14:49 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CASIF...
Mkt. cap
2.65M
Avg. vol.
2.38K
Volume
108.00
52-wk high
$0.35
52-wk low
$0.05
EPS
-$2.59
Beta
1.47
Shares outstanding
20.56M
No. of employees
214
Mkt. cap
2.65M
Avg. vol.
2.38K
Volume
108.00
52-wk high
$0.35
52-wk low
$0.05
EPS
-$2.59
Beta
1.47
Shares outstanding
20.56M
No. of employees
214
About CASI Pharmaceuticals Inc
CEO-
Employees214
Founded1991
HeadquartersRockville, Maryland, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.08M
7.22M
4.91M
4.91M
Cost of goods sold
2.37M
3.53M
1.08M
1.08M
Cost of revenue
2.37M
3.53M
1.08M
1.08M
Research and development expenses
1.41M
1.24M
1.16M
1.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.54M
14.11M
10.89M
10.89M
Operating expense
10.95M
15.35M
12.05M
12.05M
Total operating expenses
13.32M
18.88M
13.13M
13.13M
Operating income
-10.24M
-11.65M
-8.22M
-8.22M
Other non operating income
-
-15.00K
1.50K
1.50K
EBT including unusual items
-10.88M
-13.04M
-10.02M
-10.02M
EBT excluding unusual items
-10.86M
-13.04M
-10.02M
-10.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.88M
-13.04M
-10.02M
-10.02M
Net profit margin
-353.92%
-180.60%
-204.06%
-204.06%
Earnings per share
-
-
-
-
Interest and investment income
10.00K
3.00K
2.50K
2.50K
Interest expense
-195.00K
-204.00K
-671.00K
-671.00K
Net interest expenses
-185.00K
-201.00K
-668.50K
-668.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.66M
-11.34M
-7.90M
-7.90M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps